Menu
image description

Tag: Dr. Jason Knight

The LRA’s Forum for Discovery: Sharing the Latest News in Lupus Research

The Lupus Research Alliance (LRA) held our annual scientific conference, the Forum for Discovery, online in true 2020 fashion. More than 150 funded investigators, scientific advisors, and partners from the pharmaceutical and biotech industries logged on from their computers around the world to hear about new discoveries from LRA-funded researchers. LRA President Ken Farber emphasized […] Read More

LRA-Supported Study Finds Similarities in the Immune Response Between Severe COVID-19 and Lupus Antiphospholipid Syndrome

December 2, 2020 The immune response during severe COVID-19 is similar to a lupus complication known as antiphospholipid syndrome, according to a study partly funded by the Lupus Research Alliance. Dr. Jason Knight and his colleagues including rheumatologist Yu (Ray) Zuo and cardiologist Yogen Kanthi reported that 52% of patients hospitalized with severe COVID-19 had […] Read More

LRA-Funded Study Discovers Target to Lower Lupus Inflammation

April 28, 2021 In a new study led by Dr. Jason S. Knight and funded by the Lupus Research Alliance, researchers found a way to block inflammation by targeting a key protein, IRE1α, found in immune cells that are active in lupus, known as neutrophils. Dr. Knight’s team found that this protein could control some […] Read More